Hexacath
Hexacath is a company dedicated to high-tech cardiovascular solutions, focusing on innovative products and clinical excellence in the treatment of coronary and peripheral artery diseases. They develop and provide advanced medical devices such as bioactive stents, infusion catheters, and tools for microvascular resistance assessment, aiming to improve patient outcomes through evidence-based medicine and technological innovation.
Industries
Nr. of Employees
medium (51-250)
Hexacath
2 rue Joseph Monier, Batiment C, 92500 Rueil-Malmaison, France
Patents
Catheter systems and methods for performing a destruction of a body obstruction
US-11813416-B2
View DetailsDevice forming an infusion catheter for treating at least one partial or total obstruction in a passage, such as a body passage
US-11602618-B2
View DetailsThermodilution catheter systems and methods for determining blood flow rates
US-10716482-B2
View Details
Catheter systems and methods for performing a destruction of a body obstruction
US-11813416-B2
View DetailsDevice forming an infusion catheter for treating at least one partial or total obstruction in a passage, such as a body passage
US-11602618-B2
View DetailsThermodilution catheter systems and methods for determining blood flow rates
US-10716482-B2
View DetailsProducts
Bioactive coronary stent (titanium nitride oxide coated)
A coronary stent employing a titanium nitride oxide bioactive surface coating developed for treatment of acute coronary syndromes and long-term implantation with clinical outcome data.
Intracoronary multipurpose infusion catheter for thermodilution
A monorail infusion catheter intended for intracoronary saline infusion to enable continuous thermodilution-based measurement of absolute coronary blood flow and microvascular resistance.
Semi-compliant and non-compliant rapid-exchange PTCA catheters
Balloon catheters in semi-compliant and non-compliant formats for percutaneous transluminal coronary angioplasty (PTCA).
Coronary and peripheral aspiration catheter (RX format)
An aspiration catheter intended for thrombus removal or aspiration in coronary and peripheral vessels.
Bioactive coronary stent (titanium nitride oxide coated)
A coronary stent employing a titanium nitride oxide bioactive surface coating developed for treatment of acute coronary syndromes and long-term implantation with clinical outcome data.
Intracoronary multipurpose infusion catheter for thermodilution
A monorail infusion catheter intended for intracoronary saline infusion to enable continuous thermodilution-based measurement of absolute coronary blood flow and microvascular resistance.
Semi-compliant and non-compliant rapid-exchange PTCA catheters
Balloon catheters in semi-compliant and non-compliant formats for percutaneous transluminal coronary angioplasty (PTCA).
Coronary and peripheral aspiration catheter (RX format)
An aspiration catheter intended for thrombus removal or aspiration in coronary and peripheral vessels.
Services
Design and conduct support for multicenter randomized and prospective clinical trials, long-term follow-up and publication of device-related clinical outcomes.
Laboratory and animal-model testing to validate device concepts and support transition to clinical evaluation.
Management and execution of regulatory pathways for device clearance and certification in major markets.
Design and conduct support for multicenter randomized and prospective clinical trials, long-term follow-up and publication of device-related clinical outcomes.
Laboratory and animal-model testing to validate device concepts and support transition to clinical evaluation.
Management and execution of regulatory pathways for device clearance and certification in major markets.
Expertise Areas
- Clinical trial management for cardiovascular devices
- Interventional cardiology device development
- Coronary physiology measurement and analysis
- Pre-clinical device testing (in vitro and in vivo)
Key Technologies
- Titanium nitride oxide bioactive surface coating
- Continuous and bolus intracoronary thermodilution
- Monorail intracoronary infusion catheter design
- Volumetric coronary blood flow quantification
News & Updates
The world-leading course in interventional cardiovascular medicine, scheduled for 14-17 May 2024 in Paris, France.
A five-year follow-up study demonstrating the long-term efficacy and safety of Hexacath's bioactive stents in ACS patients.
Hexacath France received the Prix Galien in the 'Medical Device' category for TiTAN OPTIMAX.
The world-leading course in interventional cardiovascular medicine, scheduled for 14-17 May 2024 in Paris, France.
A five-year follow-up study demonstrating the long-term efficacy and safety of Hexacath's bioactive stents in ACS patients.
Hexacath France received the Prix Galien in the 'Medical Device' category for TiTAN OPTIMAX.